APR
Published by:
昆山市第一人民医院
Description
首次输唑来膦酸急性期反应风险预测模型是骨折风险评估的一个工具，用以评估临床上哪些患者更需要接受骨质疏松诊断和治疗。且本报告评估模型结果只是建议，具体请前往医院进行诊断。
Screenshots
APR FAQ
-
Is APR free?
Yes, APR is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is APR legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does APR cost?
APR is free.
-
What is APR revenue?
To get estimated revenue of APR app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Mexico yet.
Ratings History
APR Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
479
|
APR Installs
Last 30 days
APR Revenue
Last 30 daysAPR Revenue and Downloads
Gain valuable insights into APR performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 昆山市第一人民医院
- Languages
- English
- Recent release
- 1.0 (2 years ago )
- Released on
- Oct 9, 2022 (2 years ago )
- Also available in
- China , Portugal , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Norway , New Zealand , Peru , Philippines , Pakistan , Poland , India , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Algeria , Austria , Australia , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , Dominican Republic , Italy , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , Argentina
- Last Updated
- 4 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.